Literature DB >> 25143306

Alzheimer's disease and cancer: the need of putting research into context with previous published systematic reviews.

Ferrán Catalá-López1, Rafael Tabarés-Seisdedos.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25143306     DOI： 10.1007/s00432-014-1805-1

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  14 in total

1.  A brief history of research synthesis.

Authors:  Iain Chalmers; Larry V Hedges; Harris Cooper
Journal:  Eval Health Prof       Date:  2002-03       Impact factor: 2.651

2.  Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting.

Authors:  Mike Clarke; Sally Hopewell; Iain Chalmers
Journal:  Lancet       Date:  2010-07-03       Impact factor: 79.321

Review 3.  No paradox, no progress: inverse cancer comorbidity in people with other complex diseases.

Authors:  Rafael Tabarés-Seisdedos; Nancy Dumont; Anaïs Baudot; Jose M Valderas; Joan Climent; Alfonso Valencia; Benedicto Crespo-Facorro; Eduard Vieta; Manuel Gómez-Beneyto; Salvador Martínez; John L Rubenstein
Journal:  Lancet Oncol       Date:  2011-04-15       Impact factor: 41.316

Review 4.  Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders.

Authors:  Rafael Tabarés-Seisdedos; John L Rubenstein
Journal:  Nat Rev Neurosci       Date:  2013-04       Impact factor: 34.870

5.  Alzheimer disease and cancer risk: a meta-analysis.

Authors:  Hai-bin Shi; Bo Tang; Yao-Wen Liu; Xue-Feng Wang; Guo-Jun Chen
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-12       Impact factor: 4.553

6.  Biomedical research: increasing value, reducing waste.

Authors:  Malcolm R Macleod; Susan Michie; Ian Roberts; Ulrich Dirnagl; Iain Chalmers; John P A Ioannidis; Rustam Al-Shahi Salman; An-Wen Chan; Paul Glasziou
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

7.  How to increase value and reduce waste when research priorities are set.

Authors:  Iain Chalmers; Michael B Bracken; Ben Djulbegovic; Silvio Garattini; Jonathan Grant; A Metin Gülmezoglu; David W Howells; John P A Ioannidis; Sandy Oliver
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

8.  Increasing value and reducing waste in research design, conduct, and analysis.

Authors:  John P A Ioannidis; Sander Greenland; Mark A Hlatky; Muin J Khoury; Malcolm R Macleod; David Moher; Kenneth F Schulz; Robert Tibshirani
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

9.  Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies.

Authors:  Ferrán Catalá-López; Marta Suárez-Pinilla; Paula Suárez-Pinilla; Jose María Valderas; Manuel Gómez-Beneyto; Salvador Martinez; Vicent Balanzá-Martínez; Joan Climent; Alfonso Valencia; John McGrath; Benedicto Crespo-Facorro; Jose Sanchez-Moreno; Eduard Vieta; Rafael Tabarés-Seisdedos
Journal:  Psychother Psychosom       Date:  2014-01-22       Impact factor: 17.659

10.  Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses.

Authors:  Kristina Ibáñez; César Boullosa; Rafael Tabarés-Seisdedos; Anaïs Baudot; Alfonso Valencia
Journal:  PLoS Genet       Date:  2014-02-20       Impact factor: 5.917
View more
  2 in total

1.  Systematic reviews are rarely used to contextualise new results-a systematic review and meta-analysis of meta-research studies.

Authors:  Eva Draborg; Jane Andreasen; Birgitte Nørgaard; Carsten Bogh Juhl; Jennifer Yost; Klara Brunnhuber; Karen A Robinson; Hans Lund
Journal:  Syst Rev       Date:  2022-09-05

2.  RCAN1 in the inverse association between Alzheimer's disease and cancer.

Authors:  Qiang Fu; Yili Wu
Journal:  Oncotarget       Date:  2017-12-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.